Pharmaceutical Innovation and Production: Global Trends and Legal Challenges. New tariffs imposed by the United States starting October 1 2025… read more →
The EU pharmaceutical package aims to accelerate life sciences industries growth and promote sustainable healthcare systems for European patients. Patient access, market access, availability disparities, supply shortages, and supply chain and innovation challenges drive review and reform of the EU pharmaceutical legislation—the foundation of pharmaceutical industry manufacturing of safe, effective, high quality medicinal products in Malta and European countries.
i Classification The Medicines Authority’s Borderline Classification Committee distinguishes between medicinal and non-medicinal products. Assessments are made on a case-by-case… read more →